The Patent Finder

Lantheus Biosciences Ltd.

14 patents currently held · Updated Nov 17, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Life Molecular Imaging Limited (to 2026)

4
Ending by 2030
Oct 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Oct 12 to 19, 2027 · next Oct 12

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,266,506Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,557,776Compounds and Methods for 18F Labeled Agents
In force
 · High confidence
In forceHigh confidence
US 9,682,944Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,784,775Compounds for Use in Imaging, Diagnosing And/Or Treatment of Diseases of the Central Nervous System or of Tumors
In force
 · High confidence
In forceHigh confidence
US 8,968,701Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
In force
 · High confidence
In forceHigh confidence
US 9,592,308Method for production of F-18 labeled amyloid beta ligands
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,981,156Method for Production of F-18 Labeled Amyloid Beta Ligands
In force
 · Medium confidence
In forceMedium confidence
US 9,314,540Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,308,284Formulations of fluorinated stilbene suitable for PET imaging
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,744,252Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombi
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited